Prostate cancer ‘drug holiday’ to change care for recurring diseaseCHICAGO | Canadian research shows that men with prostate cancer who are treated with intermittent courses of androgen-suppressing therapy live as long as those who receive continuous therapy. Gardasil HPV vaccine approved for rectal cancer preventionHPV infection strongly associated with anal cancer. Memorial University School of Pharmacy to award its first PhD Mohamed Mahmoud's research involved new drug delivery system capable of providing more constant, sustained delivery of treatment for cancer. Ovarian tumour gene profile revealed Overexpression of certain proteins may guide chemotherapy Cetuximab fails in treating advanced cervical cancer Benefit in tumours with squamous cell histology not ruled out Fertility-sparing procedure safe in cervical cancer Canadian data support trachelectomy use in younger women Bladder cancer referrals blocked? Few Canadians getting neoadjuvant management, study shows Unintended tumour morcellation proves deadly Users of minimally invasive technique ‘hovering on the brink of safety’ Robot negates need for thrombosis prophylaxis Venous thromboembolism rates low after endometrial cancer surgery, suggesting heparin may be unnecessary Pomegranate may increase PSA doubling time Polyphenols and antioxidant in the fruit extract cause improved results First Previous 58 59 60 61 62 Next Last
